Z
Zhejiang Anglikang Pharmaceutical Co Ltd
SZSE:002940
Zhejiang Anglikang Pharmaceutical Co Ltd
SZSE:002940
Price:
39.8
CNY
1.63%
Market Closed
Market Cap:
¥8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Z
|
Zhejiang Anglikang Pharmaceutical Co Ltd
SZSE:002940
|
CN |
|
Dalmia Bharat Sugar and Industries Ltd
NSE:DALMIASUG
|
IN |
|
Yes Optoelectronics Group Co Ltd
SZSE:002952
|
CN |
|
Quirin Privatbank AG
XETRA:QB7
|
DE |
|
Vontron Technology Co Ltd
SZSE:000920
|
CN |
Income Statement
Earnings Waterfall
Zhejiang Anglikang Pharmaceutical Co Ltd
Zhejiang Anglikang Pharmaceutical Co Ltd
Income Statement
Zhejiang Anglikang Pharmaceutical Co Ltd
Zhejiang Anglikang Pharmaceutical Co Ltd
Currency: CNY
| Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||
| Interest Expense |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
4
|
6
|
8
|
10
|
13
|
14
|
17
|
18
|
17
|
17
|
15
|
0
|
0
|
|
| Revenue |
1 024
N/A
|
1 389
+36%
|
1 437
+3%
|
1 396
-3%
|
1 319
-6%
|
1 256
-5%
|
1 247
-1%
|
1 290
+3%
|
1 303
+1%
|
1 315
+1%
|
1 358
+3%
|
1 380
+2%
|
1 400
+1%
|
1 450
+4%
|
1 457
+0%
|
1 568
+8%
|
1 655
+6%
|
1 708
+3%
|
1 692
-1%
|
1 626
-4%
|
1 609
-1%
|
1 630
+1%
|
1 560
-4%
|
1 538
-1%
|
1 475
-4%
|
1 415
-4%
|
1 471
+4%
|
|
| Gross Profit | ||||||||||||||||||||||||||||
| Cost of Revenue |
(336)
|
(438)
|
(434)
|
(378)
|
(300)
|
(259)
|
(257)
|
(321)
|
(393)
|
(422)
|
(515)
|
(488)
|
(524)
|
(588)
|
(579)
|
(675)
|
(785)
|
(843)
|
(905)
|
(914)
|
(933)
|
(962)
|
(941)
|
(925)
|
(901)
|
(894)
|
(911)
|
|
| Gross Profit |
688
N/A
|
952
+38%
|
1 003
+5%
|
1 018
+2%
|
1 019
+0%
|
997
-2%
|
991
-1%
|
968
-2%
|
909
-6%
|
893
-2%
|
843
-6%
|
892
+6%
|
876
-2%
|
863
-2%
|
877
+2%
|
894
+2%
|
869
-3%
|
865
-1%
|
787
-9%
|
712
-10%
|
677
-5%
|
668
-1%
|
619
-7%
|
613
-1%
|
575
-6%
|
521
-9%
|
560
+8%
|
|
| Operating Income | ||||||||||||||||||||||||||||
| Operating Expenses |
(621)
|
(847)
|
(882)
|
(869)
|
(863)
|
(824)
|
(803)
|
(751)
|
(721)
|
(713)
|
(682)
|
(708)
|
(710)
|
(706)
|
(724)
|
(727)
|
(717)
|
(674)
|
(610)
|
(510)
|
(479)
|
(464)
|
(459)
|
(455)
|
(441)
|
(398)
|
(383)
|
|
| Selling, General & Administrative |
(575)
|
(797)
|
(847)
|
(838)
|
(837)
|
(804)
|
(781)
|
(737)
|
(696)
|
(678)
|
(643)
|
(664)
|
(660)
|
(638)
|
(641)
|
(613)
|
(617)
|
(573)
|
(492)
|
(399)
|
(331)
|
(292)
|
(273)
|
(274)
|
(266)
|
(260)
|
(268)
|
|
| Research & Development |
(52)
|
(57)
|
(40)
|
(32)
|
(42)
|
(45)
|
(49)
|
(35)
|
(45)
|
(49)
|
(51)
|
(43)
|
(56)
|
(69)
|
(83)
|
(100)
|
(119)
|
(127)
|
(145)
|
(128)
|
(172)
|
(191)
|
(209)
|
(200)
|
(217)
|
(197)
|
(172)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
(9)
|
0
|
0
|
0
|
(14)
|
0
|
0
|
0
|
(15)
|
0
|
0
|
0
|
(19)
|
0
|
0
|
0
|
(28)
|
0
|
0
|
0
|
(29)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
6
|
7
|
5
|
11
|
16
|
25
|
27
|
35
|
20
|
13
|
13
|
14
|
6
|
2
|
(0)
|
5
|
18
|
26
|
27
|
46
|
23
|
19
|
24
|
48
|
43
|
59
|
57
|
|
| Operating Income |
68
N/A
|
104
+54%
|
121
+16%
|
149
+23%
|
157
+5%
|
173
+10%
|
187
+9%
|
217
+16%
|
188
-13%
|
180
-5%
|
161
-10%
|
185
+14%
|
166
-10%
|
157
-6%
|
153
-2%
|
166
+8%
|
152
-9%
|
191
+26%
|
178
-7%
|
203
+14%
|
197
-3%
|
204
+3%
|
160
-21%
|
158
-1%
|
134
-15%
|
123
-8%
|
178
+44%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||
| Interest Income Expense |
4
|
9
|
12
|
7
|
8
|
9
|
7
|
15
|
12
|
10
|
8
|
10
|
16
|
23
|
27
|
11
|
6
|
2
|
0
|
10
|
9
|
6
|
5
|
4
|
0
|
(4)
|
(10)
|
|
| Non-Reccuring Items |
0
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
(22)
|
(0)
|
(0)
|
(0)
|
(21)
|
0
|
0
|
0
|
(28)
|
0
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(3)
|
(0)
|
(0)
|
(0)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
2
|
2
|
1
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
(1)
|
(1)
|
(2)
|
(1)
|
(2)
|
(1)
|
(2)
|
(1)
|
(2)
|
(2)
|
(3)
|
(5)
|
(5)
|
(5)
|
(3)
|
(1)
|
(2)
|
(3)
|
(3)
|
|
| Pre-Tax Income |
73
N/A
|
114
+56%
|
132
+16%
|
154
+16%
|
164
+7%
|
180
+10%
|
194
+8%
|
211
+9%
|
199
-5%
|
189
-5%
|
168
-11%
|
173
+3%
|
181
+5%
|
179
-1%
|
179
0%
|
147
-18%
|
157
+7%
|
191
+22%
|
175
-9%
|
207
+18%
|
202
-3%
|
205
+2%
|
162
-21%
|
158
-2%
|
133
-16%
|
117
-12%
|
164
+41%
|
|
| Net Income | ||||||||||||||||||||||||||||
| Tax Provision |
(8)
|
(16)
|
(20)
|
(27)
|
(29)
|
(30)
|
(31)
|
(29)
|
(26)
|
(24)
|
(31)
|
(31)
|
(34)
|
(27)
|
(16)
|
(15)
|
(15)
|
(18)
|
(15)
|
(24)
|
(23)
|
(25)
|
(13)
|
(6)
|
(2)
|
(6)
|
(19)
|
|
| Income from Continuing Operations |
65
|
99
|
112
|
127
|
135
|
150
|
163
|
181
|
174
|
165
|
137
|
141
|
147
|
152
|
163
|
132
|
141
|
173
|
159
|
183
|
179
|
180
|
149
|
152
|
130
|
111
|
146
|
|
| Income to Minority Interest |
(7)
|
(9)
|
(12)
|
(14)
|
(14)
|
(18)
|
(17)
|
(18)
|
(19)
|
(20)
|
(22)
|
(21)
|
(21)
|
(18)
|
(10)
|
(5)
|
(6)
|
(21)
|
(31)
|
(45)
|
(59)
|
(78)
|
(70)
|
(72)
|
(62)
|
(32)
|
(38)
|
|
| Net Income (Common) |
58
N/A
|
89
+55%
|
100
+12%
|
112
+12%
|
121
+7%
|
132
+10%
|
146
+11%
|
164
+12%
|
155
-5%
|
144
-7%
|
115
-21%
|
120
+4%
|
126
+5%
|
133
+6%
|
153
+15%
|
127
-17%
|
135
+6%
|
152
+13%
|
129
-15%
|
138
+7%
|
120
-14%
|
102
-14%
|
79
-23%
|
80
+2%
|
68
-15%
|
78
+15%
|
108
+38%
|
|
| EPS (Diluted) |
0.64
N/A
|
0.99
+55%
|
1.12
+13%
|
1.25
+12%
|
1.33
+6%
|
1.46
+10%
|
1.62
+11%
|
1.81
+12%
|
1.6
-12%
|
1.49
-7%
|
0.82
-45%
|
0.6
-27%
|
0.92
+53%
|
1
+9%
|
0.77
-23%
|
0.64
-17%
|
0.67
+5%
|
0.76
+13%
|
0.64
-16%
|
0.69
+8%
|
0.6
-13%
|
0.51
-15%
|
0.39
-24%
|
0.4
+3%
|
0.33
-18%
|
0.38
+15%
|
0.53
+39%
|
|
Switch to:
Switch to:
See Also
Discover More
